- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05548933
Effects of Non-surgical Periodontal Therapy on Severe Periodontitis and Hyperlipidemia
September 17, 2022 updated by: Second Affiliated Hospital, School of Medicine, Zhejiang University
Effects of Nonsurgical Periodontal Therapy on Biomarkers in Serum and Gingival Crevicular Fluid in Severe Periodontitis (Stage III/IV) and Hyperlipidemia:A Cohort Study
This study was a single-center, non-randomized, parallel-group design clinical trial, and each group was assigned a 1:1 ratio with or without hyperlipidemia.
Both groups underwent periodontal non-surgical treatment, and blood and gingival crevicular fluid were collected before surgery, 1 month and 3 months after surgery for the detection of MCP-1, IL-8, oxLDL, TNF-α, TG, LDL-C, HDL-C.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
This study was a single-center, non-randomized, parallel-group design clinical trial, and each group was assigned a 1:1 ratio with or without hyperlipidemia.
Both groups underwent periodontal non-surgical treatment, and blood and gingival crevicular fluid were collected before surgery, 1 month and 3 months after surgery for the detection of MCP-1, IL-8, oxLDL, TNF-α, TG, LDL-C, HDL-C.MCP-1, IL-8, oxLDL, TNF-α will be tested for concentration using ELISA.
Study Type
Observational
Enrollment (Anticipated)
64
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Yanmin Wu
- Phone Number: +86 137 5711 9560
- Email: wuyanmin@zju.edu.cn
Study Locations
-
-
Zhejiang
-
Hangzhou, Zhejiang, China, 310000
- Recruiting
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
14 years to 76 years (Adult, Older Adult)
Accepts Healthy Volunteers
N/A
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
People in Southern China
Description
Inclusion Criteria:
- Subjects had to meet at least one of the following criteria for the diagnosis of hyperlipidemia: triglyceride (TRG) levels >2.26 mmol/L; high density lipoprotein cholesterol (HDL-C) levels <1.04 mmol/L; or low density lipoprotein cholesterol (LDL-C) levels >4.14 mmol/L
- Patients with severe periodontitis (stage III/IV) with probing depth (PD) ≥ 6 mm at at least six sites, at least two multi-rooted or two single-rooted teeth in at least one quadrant, and extended bone loss on imaging to the middle or top third of the root. Periodontitis results in the loss of less than or equal to four teeth.
Exclusion Criteria:
- systemic illnesses
- pregnancy or lactation
- systemic antibiotics taken within the previous 6 months
- use of cholesterol reduction medication during the past 6 months
- subgingival scaling and root planing or surgical periodontal therapy in the last year
- chewing smokeless tobacco, smoking pipes or cigars 1 or more times per week, or smoking more than 20 cigarettes per week (1 pack per week) in the past 6 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
HP
Chronic periodontitis (stage III/IV) patients with hyperlipidemia
|
supragingival scaling,subgingival scaling
|
|
CP
Chronic periodontitis(stage III/IV) patients without hyperlipidemia
|
supragingival scaling,subgingival scaling
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
monocyte chemotactic protein-1,MCP-1
Time Frame: Before surgery
|
Concentration of MCP-1 in gingival crevicular fluids
|
Before surgery
|
|
monocyte chemotactic protein-1,MCP-1
Time Frame: 1 month after surgery
|
Concentration of MCP-1 in gingival crevicular fluids
|
1 month after surgery
|
|
monocyte chemotactic protein-1,MCP-1
Time Frame: 3 months after surgery
|
Concentration of MCP-1 in gingival crevicular fluids
|
3 months after surgery
|
|
oxidized low-density lipoprotein cholesterol, oxLDL
Time Frame: Before surgery
|
Concentration of oxLDL in gingival crevicular fluids and serum
|
Before surgery
|
|
oxidized low-density lipoprotein cholesterol, oxLDL
Time Frame: 1 month after surgery
|
Concentration of oxLDL in gingival crevicular fluids and serum
|
1 month after surgery
|
|
oxidized low-density lipoprotein cholesterol, oxLDL
Time Frame: 3 months after surgery
|
Concentration of oxLDL in gingival crevicular fluids and serum
|
3 months after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
interleukin-8,IL-8
Time Frame: Before surgery
|
Concentration of IL-8 in gingival crevicular fluids
|
Before surgery
|
|
interleukin-8,IL-8
Time Frame: 1 month after surgery
|
Concentration of IL-8 in gingival crevicular fluids
|
1 month after surgery
|
|
interleukin-8,IL-8
Time Frame: 3 months after surgery
|
Concentration of IL-8 in gingival crevicular fluids
|
3 months after surgery
|
|
triglycerides,TG
Time Frame: Before surgery
|
Concentration of TG in serum
|
Before surgery
|
|
triglycerides,TG
Time Frame: 1 month after surgery
|
Concentration of TG in serum
|
1 month after surgery
|
|
triglycerides,TG
Time Frame: 3 months after surgery
|
Concentration of TG in serum
|
3 months after surgery
|
|
low-density lipoprotein cholesterol,LDL-C
Time Frame: Before surgery
|
Concentration of LDL-C in serum
|
Before surgery
|
|
low-density lipoprotein cholesterol,LDL-C
Time Frame: 1 month after surgery
|
Concentration of LDL-C in serum
|
1 month after surgery
|
|
low-density lipoprotein cholesterol,LDL-C
Time Frame: 3 months after surgery
|
Concentration of LDL-C in serum
|
3 months after surgery
|
|
high-density lipoprotein cholesterol,HDL-C
Time Frame: Before surgery
|
Concentration of HDL-C in serum
|
Before surgery
|
|
high-density lipoprotein cholesterol,HDL-C
Time Frame: 1 month after surgery
|
Concentration of HDL-C in serum
|
1 month after surgery
|
|
high-density lipoprotein cholesterol,HDL-C
Time Frame: 3 months after surgery
|
Concentration of HDL-C in serum
|
3 months after surgery
|
|
probing depth,PD
Time Frame: Before surgery
|
The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth.
The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth.
|
Before surgery
|
|
probing depth,PD
Time Frame: 1 month after surgery
|
The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth.
The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth.
|
1 month after surgery
|
|
probing depth,PD
Time Frame: 3 months after surgery
|
The distance (mm) from the bottom of the periodontal pocket to the gingival margin was measured with a periodontal probe (UNC-15, Hu-Friedy, Chicago, IL) parallel to the long axis of the tooth.
The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth.
|
3 months after surgery
|
|
clinical attachment level,CAL
Time Frame: Before surgery
|
The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary.
The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth.
|
Before surgery
|
|
clinical attachment level,CAL
Time Frame: 1 month after surgery
|
The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary.
The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth.
|
1 month after surgery
|
|
clinical attachment level,CAL
Time Frame: 3 months after surgery
|
The periodontal probe measures the distance (mm) from the bottom of the gingival sulcus or the bottom of the periodontal pocket to the cementoenamel boundary.
The mesial, median and distal 6 points of the labial (buccal) and lingual surfaces were recorded for each tooth.
|
3 months after surgery
|
|
percentage of bleeding on probing,BOP%
Time Frame: Before surgery
|
Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding.
The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth.
Calculate the percentage of bleeding sites.
|
Before surgery
|
|
percentage of bleeding on probing,BOP%
Time Frame: 1 month after surgery
|
Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding.
The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth.
Calculate the percentage of bleeding sites.
|
1 month after surgery
|
|
percentage of bleeding on probing,BOP%
Time Frame: 3 months after surgery
|
Gently probe to the bottom of the bag or gingival sulcus, take out the probe and observe for 10-15 seconds to see if there is any bleeding.
The mesial, median and distal 6 sites of the labial (buccal) and lingual surfaces were recorded for each tooth.
Calculate the percentage of bleeding sites.
|
3 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
September 20, 2022
Primary Completion (Anticipated)
November 1, 2023
Study Completion (Anticipated)
November 1, 2023
Study Registration Dates
First Submitted
September 13, 2022
First Submitted That Met QC Criteria
September 17, 2022
First Posted (Actual)
September 22, 2022
Study Record Updates
Last Update Posted (Actual)
September 22, 2022
Last Update Submitted That Met QC Criteria
September 17, 2022
Last Verified
September 1, 2022
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2022-0567
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biomarkers
-
Fu Jen Catholic University HospitalRecruitingPerimenopausal Biomarkers | Mitochondrial BiomarkersTaiwan
-
Instituto Nacional de Ciencias Medicas y Nutricion...CompletedNutrition, Biomarkers of Intake, Urinary Biomarkers, Foodomics, MetabolomMexico
-
Peking UniversityCompleted
-
University of MinnesotaCompleted
-
University of California, DavisUSDA, Western Human Nutrition Research CenterCompleted
-
Harvard School of Public Health (HSPH)CompletedBiomarkersUnited States
-
West China HospitalRecruitingBiomarkers | NeonateChina
-
U.S. Army Medical Research and Development CommandWalter Reed Army Institute of Research (WRAIR)CompletedBiomarkers, PharmacologicalUnited States
-
Eman Ashraf Saad AhmedNot yet recruiting
-
Pirogov Russian National Research Medical UniversityRecruitingBiomarkers | Healthy AgingRussia
Clinical Trials on non-surgical periodontal therapy
-
Cairo UniversityGulf Medical UniversityNot yet recruiting
-
Medipol UniversityCompletedPeriodontitis | Periodontal Therapy | Probiotic | Oral Hygiene, Oral HealthUnited States
-
CAIO VINICIUS GONÇALVES ROMAN TORRESCompletedRheumatoid Arthritis | Periodontitis
-
Ain Shams UniversityRecruiting
-
University of SharjahRecruitingInflammation | PeriodontitisUnited Arab Emirates
-
University of SienaNot yet recruitingPeriodontal Therapy | Non Responding Sites
-
Kırıkkale UniversityCompletedPeriodontal Diseases
-
Nada Mahmoud SolimanRecruitingStage III PeriodontitisEgypt
-
Ömer Faruk OkumuşErzincan Binali Yildirim UniversitesiRecruitingPeriodontitis | Periodontal Diseases | Gingivitis; ChronicTurkey (Türkiye)